96 related articles for article (PubMed ID: 16818284)
1. The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients.
Malik E; Cohen SB; Sahar D; Dann EJ; Rund D
Haematologica; 2006 Jul; 91(7):956-9. PubMed ID: 16818284
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
4. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS.
Fern L; Pallis M; Ian Carter G; Seedhouse C; Russell N; Byrne J
Br J Haematol; 2004 Jul; 126(1):63-71. PubMed ID: 15198733
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between GSTT1, GSTM1 and NQO1 gene polymorphism and acute myeloid leukemia and recurrent chromosome translocations].
Yang L; Zhang Y; Zhang MR; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2312-6. PubMed ID: 16321221
[TBL] [Abstract][Full Text] [Related]
6. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.
Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P
Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791
[TBL] [Abstract][Full Text] [Related]
8. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
10. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
11. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy.
Toncheva DI; Von Ahsen N; Atanasova SY; Dimitrov TG; Armstrong VW; Oellerich M
J Nephrol; 2004; 17(3):384-9. PubMed ID: 15365958
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
Li C; Liu Y; Wei S; Zhou Y
Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
[TBL] [Abstract][Full Text] [Related]
13. High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8.
Zachaki S; Stavropoulou C; Koromila T; Manola KN; Kalomoiraki M; Daraki A; Koumbi D; Athanasiadou A; Kanavakis E; Kollia P; Sambani C
Leuk Res; 2013 Jul; 37(7):742-6. PubMed ID: 23643325
[TBL] [Abstract][Full Text] [Related]
14. Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults.
Smith MT; Wang Y; Kane E; Rollinson S; Wiemels JL; Roman E; Roddam P; Cartwright R; Morgan G
Blood; 2001 Mar; 97(5):1422-6. PubMed ID: 11222389
[TBL] [Abstract][Full Text] [Related]
15. High risk of 'de novo' acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects.
Yamaguti GG; Lourenço GJ; Costa FF; Lima CS
Eur J Haematol; 2009 Sep; 83(3):270-2. PubMed ID: 19456854
[No Abstract] [Full Text] [Related]
16. [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].
Ma QL; Yang JF; Shao M; Dong XM; Chen B
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2124-7. PubMed ID: 14720419
[TBL] [Abstract][Full Text] [Related]
17. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
18. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
Hu LT; Stamberg J; Pan S
Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
[TBL] [Abstract][Full Text] [Related]
19. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
20. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]